Anti-citrullinated protein antibodies are not associated with extent of disease or prognosis in patients with coronary artery disease

Clin Chem Lab Med. 2019 Jun 26;57(7):e159-e161. doi: 10.1515/cclm-2018-1097.
No abstract available

Keywords: biomarker; coronary artery disease; inflammation; prognosis.

Publication types

  • Letter

MeSH terms

  • Aged
  • Anti-Citrullinated Protein Antibodies / blood*
  • Area Under Curve
  • Citrulline / immunology
  • Coronary Artery Disease / diagnosis*
  • Coronary Artery Disease / drug therapy
  • Coronary Artery Disease / pathology
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Immunoassay / methods
  • Male
  • Middle Aged
  • Prognosis
  • ROC Curve
  • Risk Factors
  • Severity of Illness Index

Substances

  • Anti-Citrullinated Protein Antibodies
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Citrulline